TickerLeague

Buyback Spend for Elevance Health (ELV)

Buyback Spend for Elevance Health (ELV): headline value $2.85B · YoY -10.2%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Latest period

$2.85B

YoY change

-10.2%

5Y CAGR

-0.7%

Peak year (2007)

$6.15B

Latest annual

$2.60B

Buyback Spend history chart for Elevance Health (ELV) from 2001 to 2025

Buyback Spend history table for Elevance Health (ELV) from 2001 to 2025

Fiscal yearPeriod endedReportedBuyback SpendYoY
2025$2.60B-10.2%
2024$2.90B+8.4%
2023$2.68B+15.5%
2022$2.32B+21.9%
2021$1.90B-29.6%
2020$2.70B+58.7%
2019$1.70B+0.9%
2018$1.69B-15.7%
2017$2.00B+2881.6%
2016$67.00M-95.6%
2015$1.52B-49.5%
2014$3.00B+85.1%
2013$1.62B-35.1%
2012$2.50B-17.9%
2011$3.04B-30.3%
2010$4.36B+65.3%
2009$2.64B-19.5%
2008$3.28B-46.7%
2007$6.15B+35.2%
2006$4.55B+1264.8%
2005$333.40M+305.6%
2004$82.20M-62.2%
2003$217.20M-15.2%
2002$256.20M
2001$0

Buyback Spend values are taken from Elevance Health's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

2025's annual buyback spend for Elevance Health (ELV) came in at $2.60B – declined 10.2% year-over-year.

Elevance Health buyback spend has contracted on net over the period, with a -0.7% compound annual growth rate over 2020–2025 (5 years).

Elevance Health buyback spend peaked at $6.15B in 2007; the latest annual figure is $2.60B in 2025 (57.7% below peak).

The highest annual buyback spend of $6.15B was reported in 2007. The lowest in the available history was $0 in 2001.

Elevance Health (ELV) sits 5th of 8 Healthcare peers we track on this metric, against a peer median of $2.75B.

Elevance Health Buyback Spend by Year

Elevance Health Buyback Spend 2025: $2.60B

Elevance Health buyback spend in 2025 was $2.60B, declined 10.2% below 2024.

Elevance Health Buyback Spend 2024: $2.90B

Elevance Health buyback spend in 2024 was $2.90B, grew 8.4% from 2023.

Elevance Health Buyback Spend 2023: $2.68B

Elevance Health buyback spend in 2023 was $2.68B, grew 15.5% from 2022.

Elevance Health Buyback Spend 2022: $2.32B

Elevance Health buyback spend in 2022 was $2.32B, grew 21.9% from 2021.

Elevance Health Buyback Spend 2021: $1.90B

Elevance Health buyback spend in 2021 was $1.90B.

See more financial history for Elevance Health (ELV).

Sector peers — Buyback Spend

Companies in the same sector as Elevance Health, ranked by their latest buyback spend.

CompanyBuyback SpendSector
Johnson & Johnson (JNJ)$5.95BHealthcare
UnitedHealth Group Incorporated (UNH)$5.54BHealthcare
Merck & Co., Inc. (MRK)$5.08BHealthcare
Eli Lilly and Company (LLY)$4.11BHealthcare
Novo Nordisk A/S (NVO)$1.39BHealthcare
AbbVie Inc. (ABBV)$980.00MHealthcare
AstraZeneca PLC (AZN)$719.66MHealthcare
Amgen Inc. (AMGN)$0Healthcare

Frequently asked questions

What is Elevance Health's buyback spend?

Latest reported buyback spend for Elevance Health (ELV) is $2.85B (period ending March 31, 2026).

How has Elevance Health buyback spend changed year-over-year?

Elevance Health (ELV) buyback spend changed -10.2% year-over-year on the latest annual filing.

What is the long-term growth rate of Elevance Health buyback spend?

Elevance Health (ELV) buyback spend compound annual growth rate is -0.7% over the most recent 5 years available.

When did Elevance Health buyback spend hit its highest annual value?

Elevance Health buyback spend reached its highest annual value of $6.15B in 2007.

What was Elevance Health buyback spend in 2024?

Elevance Health (ELV) buyback spend in 2024 was $2.90B.

What was Elevance Health buyback spend in 2025?

Elevance Health (ELV) buyback spend in 2025 was $2.60B.

Metrics overview

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.